Protocol Snapshot

Quick reference before the deep dive

Verified Vendors

Humanin

Compare Verified Vendors

Current price and availability
Price per mg and vial-size comparison
Testing and fulfillment details

Compare

View Price Index

Low Dose

25–50mcg

Anecdotal once-daily community use.

Standard Community Dose

500mcg–1mg

Once or twice daily for 10–15 days.

Class

MDP

Review the full protocol details below.

Primary Use

Cell Protection

Review the full protocol details below.

Peptide Grade

GradeC

Humanin has unusually broad cell-protection, metabolic, and neurodegenerative research signals, but almost no human dosing evidence and unresolved tumor-context concerns limit the grade.

Research Community Safety

Foundation

Research context, mechanisms, and practical use cases

What is Humanin?

Humanin is a 24-amino-acid peptide encoded by a short open reading frame within the mitochondrial 16S ribosomal RNA region. It belongs to a family of mitochondrial-derived peptides, or MDPs, which also includes MOTS-c and the small humanin-like peptides.

Humanin was first described in 2001 after researchers isolated a cDNA associated with surviving neurons from the brain of a patient with Alzheimer’s disease. Laboratory experiments showed that the peptide could protect neuronal cells from amyloid-beta-related toxicity.

Unlike many research peptides, Humanin is naturally produced in the body. It has been detected in multiple tissues and in circulation, where it appears to participate in stress signaling between mitochondria and the rest of the cell.

Humanin acts through several mechanisms, including a tripartite cell-surface receptor complex, direct interaction with pro-apoptotic proteins such as BAX, modulation of PI3K-AKT and AMPK signaling, regulation of oxidative stress, and effects on insulin action.

The Longevity Connection

Humanin levels tend to decline with age in several species. In a 2020 observational study, levels remained relatively stable across the long lifespan of naked mole-rats and were higher in offspring of centenarians than in age-matched controls. These associations do not prove that raising Humanin extends human life.

Native Humanin appears to have a short circulating half-life in rodents. HNG, also called S14G-Humanin, replaces serine with glycine at position 14 and is substantially more potent in many experimental systems.

Humanin and HNG are not FDA approved. No completed human intervention trial has established an effective dose, treatment schedule, long-term safety profile, or clinical indication.

Potential Humanin Benefits

The evidence base includes cell culture, animal models, and observational human studies. Direct administration has not been validated in completed human clinical trials.

Neuroprotection

Humanin and HNG protect neurons in amyloid-beta models and have improved learning, memory, plaque burden, and tau-related markers in Alzheimer’s mouse models. Additional preclinical work spans stroke, traumatic brain injury, Parkinsonian models, and age-related cognitive decline.

Cardioprotection

HNG reduced infarct size and improved post-ischemic cardiac function in mouse studies, with supportive findings in a pig ischemia-reperfusion model. AMPK, eNOS, oxidative-stress regulation, and anti-apoptotic signaling appear involved.

Insulin Sensitivity

Central Humanin administration improved hepatic and skeletal-muscle insulin sensitivity in rats. Potent analogs also enhanced glucose-stimulated insulin secretion in mouse pancreatic islets.

Lifespan & Healthspan

Humanin overexpression extended lifespan in C. elegans through a FOXO-dependent pathway. Twice-weekly HNG did not extend mouse lifespan in one study but improved body composition, inflammatory markers, IGF-I, and memory-related measures.

Muscle Protection

A 2026 human skeletal-muscle cell study found that Humanin analog treatment partially attenuated dexamethasone-induced atrophy and STAT3 activation. MOTS-c produced stronger protection in the same model.

Inflammation Resolution

A 2025 study reported that human macrophages performing efferocytosis produce Humanin and that this signaling supports resolution of inflammation.

Atherosclerosis Research

In ApoE-deficient mice, the HNGF6A analog reduced aortic plaque burden, endothelial dysfunction, oxidative stress, and plaque-cell apoptosis without directly lowering cholesterol.

Chemotherapy Side-Effect Research

Some mouse studies suggest Humanin analogs may protect healthy tissues during chemotherapy. Other cancer models found the opposite—promotion of tumor progression and impaired chemotherapy response—making this area highly context dependent.

Protocol Planning

Dosing, cycling, and preparation

Humanin Dosing Protocol

These schedules come from sparse community use, often involving HNG rather than native Humanin. They are not clinically validated and should not be confused with animal-study doses.

Community Protocol

Low Dose

25–50mcg subcutaneously once daily

Standard Dose

500mcg–1mg subcutaneously once or twice daily

Cycle Length

10–15 days

Frequency

Anecdotally repeated several times per year

Timing Considerations

Common Timing

Morning administration

Optimal Timing

No published human data

Fasting

No established fasting requirement

Twice Daily

Theoretical strategy for more sustained exposure; not clinically validated

Native Humanin vs. HNG

Humanin and HNG are not interchangeable on a potency-for-potency basis. HNG is a modified analog with greater activity in many experimental systems, so community reports should specify which compound was used.

Humanin Reconstitution

The following example uses a 10mg vial with 2mL of bacteriostatic water.

10mg Vial

Vial Size

10mg

BAC Water

2mL

Concentration

5mg/mL (5,000mcg/mL)

1mg

20 units on a U-100 insulin syringe

500mcg

10 units

50mcg

1 unit

25mcg

0.5 units — difficult to measure accurately

Reconstitution Calculator

Handling Notes

Mixing

Add bacteriostatic water to the vial.

Do Not

Do not shake aggressively.

Storage

Refrigerate after reconstitution.

Low-Dose Issue

A more dilute preparation may be needed for accurate 25–50mcg measurements.

Anecdotal Data Points

Community-reported outcomes and recurring patterns

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

Better sleep and smoother energy are among the more commonly described early effects.
Some users report improved exercise recovery, though reports remain sparse and inconsistent.

Negative or Neutral Reports

Humanin has a much smaller self-experimentation community than most commonly discussed peptides, leaving very little report volume to evaluate.
Most users combine Humanin with other compounds, making it difficult to attribute any reported effect specifically to Humanin or HNG.

Stacking & Synergy

Potential Humanin pairings and tracking context

Humanin Stacking & Synergy

Humanin + MOTS-c

Both are mitochondrial-derived peptides but emphasize different pathways. MOTS-c is commonly framed around AMPK and exercise-like metabolic signaling, while Humanin is discussed more as a stress-protective and anti-apoptotic peptide. No human combination trial exists.

Humanin + SS-31

SS-31 targets cardiolipin and inner-mitochondrial-membrane stability, while Humanin influences ROS, membrane potential, and apoptosis signaling. The mechanisms are theoretically complementary but untested together.

Humanin + NAD+ Precursors

Humanin is intended to address mitochondrial stress and cell-survival signaling, while NAD+ precursors support metabolic cofactors and repair pathways. No established interaction data exists.

Humanin + FOXO4-DRI

This is a highly theoretical pairing involving distinct aging and apoptosis pathways. Humanin has FOXO-linked longevity findings in worms, while FOXO4-DRI disrupts FOXO4-p53 signaling in senescent cells. No combination data exists.

These combinations are speculative. Because Humanin can be anti-apoptotic, stacking it with senolytic or cancer-related agents deserves particular caution.

Free with login

Track in Journal

Track Humanin with the markers that matter most for this compound.

Dose, timing, fasting context, and cycle day.
Daily energy, exercise tolerance, and metabolic response.
Sleep, recovery, glucose trends, and injection-site effects.

Start Tracking

Safety Notes

Side effects, contraindications, and precautions

Humanin Side Effects

Published animal studies generally describe Humanin and its analogs as well tolerated under the tested conditions. That does not establish safety for injected Humanin or HNG in humans.

Endogenous production does not guarantee that supraphysiologic dosing, repeated injection, or more potent analogs are safe. Dose, duration, tissue exposure, product purity, and tumor context all matter.

Community / Immediate Reports

Mild injection-site redness, swelling, or discomfort.
Occasional gastrointestinal discomfort.
Fatigue, headache, or nonspecific malaise are possible but poorly characterized.
No reliable pattern of serious adverse effects can be inferred from the very small user base.

Theoretical / Research Concerns

Anti-apoptotic signaling could protect unwanted or malignant cells in some contexts.
Sustained Humanin overexpression impaired growth and reproductive output in animal models.
Repeated exposure to synthetic analogs may carry unknown immune or off-target risks.
Long-term human organ, reproductive, metabolic, and cancer risks are unknown.

Cancer Concern

A 2020 triple-negative breast cancer mouse study found that exogenous Humanin promoted tumor progression and metastasis and impaired doxorubicin effectiveness. Other models suggest Humanin may protect healthy tissue during chemotherapy. Until these conflicting effects are understood, active or prior cancer warrants strict medical oversight.

Humanin Contraindications and Precautions

Do Not Use If You Have

Active cancer or a known tumor, particularly without oncology supervision.
A history of cancer—especially breast cancer—unless your oncologist specifically approves use.
Current chemotherapy treatment without direct oncologist guidance.
Known hypersensitivity to Humanin, HNG, or formulation ingredients.

Use Caution With

A strong family history of cancer because of unresolved anti-apoptotic concerns.
Pregnancy or breastfeeding, because no safety data exists.
Autoimmune conditions, because Humanin modulates immune and inflammatory signaling.
Children or adolescents, given developmental growth and reproductive findings in animal models.

Drug Interactions

No well-established human interaction profile exists. Chemotherapy interactions are a major theoretical and preclinical concern. Because Humanin can improve insulin sensitivity in animal models, people using insulin or glucose-lowering medications could theoretically face altered blood-glucose responses.

Regulatory Status

Humanin and HNG are not FDA approved for any indication. No completed human intervention trials have established dosing, efficacy, or long-term safety.

FINAL VERDICT

Peptide Protocol's Opinionated Opinion

This is not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

We rate Humanin as a high-value mitochondrial and neuroprotective peptide. Users often report better cellular energy, improved stress resilience, and clearer cognition, particularly when under high training or mental demands. It’s frequently praised for its protective effects on mitochondria and neurons in longevity-focused circles.

Quietly powerful and consistently well-regarded. Excellent addition for anyone serious about mitochondrial optimization and long-term brain health. We like including it in stacks with MOTS-c or SS-31 for metabolic and cognitive synergy.

That said, like most peptides, Humanin is not entirely risk-free. While we have not seen major negative reports in common use, long-term safety data in humans is limited, and some users report mild headaches or fatigue at higher doses. We recommend starting low and cycling it rather than using it indefinitely. Overall, it remains one of the cleaner options in the mito category, but respect the lack of extensive long-term human studies.